396 related articles for article (PubMed ID: 23539116)
1. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
[TBL] [Abstract][Full Text] [Related]
2. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion.
Bonifacio E; Krumsiek J; Winkler C; Theis FJ; Ziegler AG
Acta Diabetol; 2014; 51(3):403-11. PubMed ID: 24249616
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
[TBL] [Abstract][Full Text] [Related]
4. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
[TBL] [Abstract][Full Text] [Related]
5. Non-HLA gene effects on the disease process of type 1 diabetes: From HLA susceptibility to overt disease.
Lempainen J; Laine AP; Hammais A; Toppari J; Simell O; Veijola R; Knip M; Ilonen J
J Autoimmun; 2015 Jul; 61():45-53. PubMed ID: 26074154
[TBL] [Abstract][Full Text] [Related]
6. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
[TBL] [Abstract][Full Text] [Related]
7. Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes?
Steck AK; Xu P; Geyer S; Redondo MJ; Antinozzi P; Wentworth JM; Sosenko J; Onengut-Gumuscu S; Chen WM; Rich SS; Pugliese A;
J Clin Endocrinol Metab; 2017 Aug; 102(8):2873-2880. PubMed ID: 28520980
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
[TBL] [Abstract][Full Text] [Related]
9. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
[TBL] [Abstract][Full Text] [Related]
10. CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients.
Vandewalle J; Desouter AK; Van der Auwera BJ; Tenoutasse S; Gillard P; De Block C; Keymeulen B; Gorus FK; Van de Casteele M;
Clin Exp Immunol; 2023 Mar; 211(3):224-232. PubMed ID: 36622793
[TBL] [Abstract][Full Text] [Related]
11. Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives.
Wang JP; Zhou ZG; Lin J; Huang G; Zhang C; Yang L; Yuan Y; Zhou HF; Zhou M; Hou C; Zhou WD; Peng H; Hagopian WA
Tissue Antigens; 2007 Nov; 70(5):369-75. PubMed ID: 17919266
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Slow Progression to Type 1 Diabetes in Children With Increased HLA-Conferred Disease Risk.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Ilonen J; Siljander H; Knip M
J Clin Endocrinol Metab; 2019 Nov; 104(11):5585-5594. PubMed ID: 31314077
[TBL] [Abstract][Full Text] [Related]
13. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
[TBL] [Abstract][Full Text] [Related]
14. Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and
Gorus FK; Balti EV; Messaaoui A; Demeester S; Van Dalem A; Costa O; Dorchy H; Mathieu C; Van Gaal L; Keymeulen B; Pipeleers DG; Weets I;
Diabetes Care; 2017 Aug; 40(8):1065-1072. PubMed ID: 28701370
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study.
Long AE; Wilson IV; Becker DJ; Libman IM; Arena VC; Wong FS; Steck AK; Rewers MJ; Yu L; Achenbach P; Casas R; Ludvigsson J; Williams AJK; Gillespie KM
Diabetologia; 2018 Jun; 61(6):1484-1490. PubMed ID: 29532109
[TBL] [Abstract][Full Text] [Related]
16. Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1).
Butty V; Campbell C; Mathis D; Benoist C;
Diabetes; 2008 Sep; 57(9):2348-59. PubMed ID: 18556337
[TBL] [Abstract][Full Text] [Related]
17. Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident β-cell autoantibodies.
Lynch KF; Lee HS; Törn C; Vehik K; Krischer JP; Larsson HE; Haller MJ; Hagopian WA; Rewers MJ; She JX; Simell OG; Toppari J; Ziegler AG; Akolkar B; Hyöty H; Bonifacio E; Lernmark Å;
J Autoimmun; 2018 Jan; 86():93-103. PubMed ID: 28941965
[TBL] [Abstract][Full Text] [Related]
18. Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.
Maziarz M; Hagopian W; Palmer JP; Sanjeevi CB; Kockum I; Breslow N; Lernmark Å; ; ;
Genes Immun; 2015 Dec; 16(8):541-51. PubMed ID: 26513234
[TBL] [Abstract][Full Text] [Related]
19. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
[TBL] [Abstract][Full Text] [Related]
20. Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes?
Steck AK; Zhang W; Bugawan TL; Barriga KJ; Blair A; Erlich HA; Eisenbarth GS; Norris JM; Rewers MJ
Diabetes; 2009 Apr; 58(4):1028-33. PubMed ID: 19188433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]